South Wales, July 10 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "TREZULDO" on June 30. The details about the trademark application no. UK00004409420 published in the journal no. 2026/028 (July 10).
With Appleyard Lees IP LLP as representative, Regeneron Pharmaceuticals, Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy; Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral, and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of obesity.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004409420
Disclaimer: Curated by HT Syndication.
